Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftobiprole in Community-Acquired Pneumonia
NCT00326287Phase 3Completed
- Sponsor
- Basilea Pharmaceutica
- Start
- Jun 2006
- Primary completion
- Jul 2007
- Modality
- Reversible Covalent Inhibitors
01
Overview
A Phase 3 trial of ceftobiprole medocaril in community acquired pneumonia (CAP), sponsored by Basilea Pharmaceutica. Started Jun 2006; status: completed.
02
Drugs
ceftobiprole medocaril
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT00326287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00326287.